Laboratory diagnosis of ANA, anti-dsDNA- and anti-ENA- antibodies; recommendations following the outcomes of a questionaire;Laboratoriumdiagnostiek van ANA, anti-ds-DNA- En anti-ENA-antistoffen: aanbevelingen naar aanleiding van een enquête

Nederlands Tijdschrift voor Klinische Chemie en Laboratoriumgeneeskunde

Volumn 35, Issue 4, 2010, Pages 234-239

  Damoiseaux, J ^a   Bakker Jonges, L ^b   Cohen Tervaert, J W ^a   Derksen, R ^c   Hooijkaas, H ^d   Kallenberg, C ^e   Klasen, I ^f   Limburg, P ^e   Smeenk, R ^g   Hamann, D ^g  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b REINIER DE GRAAF HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g CENTRAL LABORATORY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI DOUBLE STRANDED ANTIBODY; ANTI ENA ANTIBODY; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CELL NUCLEUS ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; HUMAN; LABORATORY TEST; PRACTICE GUIDELINE; QUALITY CONTROL; STRUCTURED QUESTIONNAIRE;

EID: 78349261504     PISSN: 15708306     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Shoenfeid Y, Cervera R, Haass M, Kallenberg C, Khamashta M, Meroni L, Piette J-C, Schmidt R, Wiik A. EASI - The European Autoimmunity Standardisation Initiative. A new initiative that can contribute to agreed diagnostic models of diagnosing autoimmune disorders throughout Europe. Ann NY Acad Sci 2007; 1109: 138-144.
2. Damoiseaux J, Cohen Tervaert JW, Derksen R, Hamann D, Hooijkaas H, Klasen I. Kallenberg C. Limburg P, Smeenk R. Autoantibody standardization in the Netherlands. The past, the present, and the future. Ann NY Acad Sci 2009; 1173: 10-14.
3. Pekelharing JM, Hooijkaas H, Punt JMHM, Smeets LC, Souverijn JHM. Handboek medische laboratoriumdiagnostiek. Compendium Klinische Diagnostiek - Deel 2. Houten, The Netherlands: Prelum uitgevers; 2009.
4. CBO-richtlijn: Dermatomyositis, polymyositis en sporadische 'inclusion body'-myositis. Alphen aan den Rijn, The Netherlands: Van Zuiden Communications; 2005.
5. CBO-richtlijn: Diagnostiek en behandeling van reumatoïde artritis. Alphen aan den Rijn, The Netherlands: Van Zuiden Communications; 2009.
6. CBO-richtlijn: Diagnostiek kleine vaten vasculitis. Alphen aan den Rijn, The Netherlands: Van Zuiden Communications; in druk.
7. Hooijkaas H, Smeenk R, Gmelig Meyling F. Systemische auto-immuunziekten: passende serologische diagnostiek. Ned Tijdschr Klin Chem Labgeneeskunde 2006: 31: 257-268.
8. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
9. Kroshinsky D, Stone JH, Bloch DB, Sepehr A. Case 5-2009: a 47-year-old woman with a rash and numbness and pain in the legs. N Engl J Med 2009; 360: 711-720.
10. American College of Rheumatology. Position statement: methodology of testing for antinuclear antibodies. 2009; www.rheumatology.org/practice/ clinical/position/ana-position-stmt.pdf.
11. Tan EM, Feltkamp TEW, Smolen JS, Butcher B, Dawkins R, Fritzler MJ, Gordon T, Hardin JA, Kalden JR, Lahita RG, Maini RN, McDougal JS, Rothfield NF, Smeenk RJ, Takasaki Y, Wiik A, Wilson MR, Koziol JA. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum 1997; 40: 1601-1611.
12. Van Blerk M, Van Campenhout C, Bossuyt X, Duchateau J, Humbel R, Servais G, Tomasi J-P, Albert A, Coucke W, Libeer J-C. Current practices in antinuclear testing: results from the Belgian External Quality Assessment Scheme. Clin Chem Lab Med 2009; 47: 102-108.
13. Damoiseaux JGMC, Cohen Tervaert JW. From ANA to ENA: how to proceed? Autoimmunity Rev 2006; 5: 10-17.
14. Hahn BH. Antibodies to DNA. N Eng J Med 1998; 338: 1359-1368.
15. Venrooij WJ van, Charles P, Maini RN. The consensus workshops for the detection of autoantibodies to intracellular antigens in rheumatic diseases. J Immunol Meth 1991; 140: 181-189.
16. Boire G, Gendron M, Monast N, Bastin B, Menard HA. Purification of antigenically intact Ro ribonuleoproteins; biochemical and immunological evidence that the 52-kD protein is not a Ro protein. Clin Exp Immunol 1997; 100: 489-498.
17. Friedman DM, Rupel A, Buyon JP. Epidemiology, etiology, detection, and treatment of autoantibody-associated congenital heart block in neonatal lupus. Curr Rheumatol Rep 2007; 9: 101-108.
18. Schulte-Pelkum J, Fritzler M, Mahler M. Latest update on the Ro/SS-A autoantibody system. Autoimmun Rev 2009; 8: 632-637.
19. Kang I, Spierstein R, Quan T, Breittenstein ML. Utility of age, gendre, ANA titer and pattern as predictors of anti-ENA and dsDNA antibodies. Clin Rheumatol 2004; 23: 50-51.